Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting

By Maham Fatima | June 24, 2025, 3:09 PM

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the best mid cap growth stocks to invest in now. Earlier on June 11, Lantheus Holdings announced that new data highlighting two oncology radiodiagnostic agents will be presented at the upcoming 2025 Society of Nuclear Medicine and Molecular Imaging/SNMMI Annual Meeting. The meeting is scheduled to take place from June 21-24, 2025, in New Orleans, LA.

An oral presentation titled ‘Optimized Production and Quality Control of the FAP imaging Agent [64Cu]LNTH-1363S’ will be given by Gengyang Yuan of Lantheus on June 24 during Session Number SS39. Three poster presentations are also planned.

Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting
A medical professional performing a pulmonary function assessment on a patient.

On June 22, during Session Number MTA03, Amir Iravani from the University of Washington will present ’18F-Piflufolastat PET/CT in Patients with Biochemically Recurrent Prostate Cancer: a CONDOR Sub-analysis of Positive Predictive Value in the Prostate/Prostatic Bed Stratified by PSA.’

On June 23, Ida Sonni from the University of California, Los Angeles, will present ‘First Clinical Evaluation of 68Ga-LNTH-1363S, a Novel FAP-Targeting Radiopharmaceutical for PET Imaging: Physiological Biodistribution and Tumor Uptake in Cancer Patients’ during Session Number MTA06.

Finally, June 24, Gyu Seong Heo from the Department of Radiology, Washington University, will present ‘Preclinical assessment of 64Cu-LNTH-1363S for FAP PET imaging in mouse models of myocardial infarction’ during Session Number SS27.

Lantheus Holdings Inc. (NASDAQ:LNTH) develops, manufactures, and commercializes diagnostic & therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

While we acknowledge the potential of LNTH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News

Jun-24
Jun-23
Jun-11
Jun-10
Jun-03
Jun-02
May-14
May-09
May-08
May-08
May-08
May-08
May-07
May-07
May-07